Barclays Maintains Underweight on XPeng, Lowers Price Target to $16

Barclays analyst Jiong Shao has maintained an Underweight rating on XPeng (NYSE: XPEV) and has lowered the price target from $17 to $16. This adjustment reflects the bank's cautious outlook on the company's performance.